OTTAWA — Canada's national Inuit organization is calling on the federal government to be better partners, saying Canada must respect Inuit rights to governance and self-determination. Inuit Tapiriit ...

Claude Code started as a terminal coding assistant. It now runs as a layered agentic system. Underneath, Claude Code separates memory, hooks, skills, subagents, plugins, and MCP into distinct layers.

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Inuit Tapiriit ...

The organization representing Inuit in Canada says the federal government program meant to subsidize the high cost of food in the North isn’t working and should be scrapped. The call to shut down ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

The last time I spoke about Corvus Pharmaceuticals, Inc. (CRVS), it was in a Seeking Alpha article entitled "Corvus Pharmaceuticals: Positive Phase 1 Soquelitinib Trial Data Brings 2025 Catalysts." ...

ITK inhibitors block the secretion of proteins that can cause inflammation and an errant immune response, making them potentially useful in treating autoimmune disorders. In eczema, those responses ...

As we all know, ChatGPT is a large language model (LLM) that is trained on a wide variety of massive data. It includes data from general knowledge, common sense, reasoning, mathematical problems, ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

- Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS) ...

Data published in peer-reviewed npj Drug Discovery, a Nature portfolio journal BURLINGAME, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage ...